Trivalent inactivated influenza vaccine (IIV3) during pregnancy and six-month infant development
- 4 February 2020
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 38 (10), 2326-2332
- https://doi.org/10.1016/j.vaccine.2020.01.059
Abstract
No abstract availableKeywords
Funding Information
- Centers for Disease Control and Prevention
- National Institutes of Mental Health (K01MH103444)
This publication has 39 references indexed in Scilit:
- Risk of Fetal Death after Pandemic Influenza Virus Infection or VaccinationNew England Journal of Medicine, 2013
- Evaluating the Hazard of Foetal Death following H1N1 Influenza Vaccination; A Population Based Cohort Study in the UK GPRDPLOS ONE, 2012
- Modeling an autism risk factor in mice leads to permanent immune dysregulationProceedings of the National Academy of Sciences, 2012
- Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autismBrain, Behavior, and Immunity, 2012
- Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: A case-control studyMolecular Autism, 2011
- Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births: A Retrospective Cohort StudyPLoS Medicine, 2011
- Maternal infection and immune involvement in autismTrends in Molecular Medicine, 2011
- Maternal Influenza Infection During Pregnancy Impacts Postnatal Brain Development in the Rhesus MonkeyBiological Psychiatry, 2010
- Baseline Levels of Influenza-Specific CD4 Memory T-Cells Affect T-Cell Responses to Influenza VaccinesPLOS ONE, 2008
- Cellular Immune Responses in Children and Adults Receiving Inactivated or Live Attenuated Influenza VaccinesJournal of Virology, 2006